Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017;56(9):1041-1048.
doi: 10.2169/internalmedicine.56.7761. Epub 2017 May 1.

Isolated Gastric Varices Refractory to Balloon-occluded Retrograde Transvenous Obliteration (BRTO) Successfully Treated by Shunt-occluded Endoscopic Injection Sclerotherapy (SO-EIS): A Case Report and Review of the Literature

Affiliations
Review

Isolated Gastric Varices Refractory to Balloon-occluded Retrograde Transvenous Obliteration (BRTO) Successfully Treated by Shunt-occluded Endoscopic Injection Sclerotherapy (SO-EIS): A Case Report and Review of the Literature

Takeshi Hatanaka et al. Intern Med. 2017.

Abstract

Balloon-occluded retrograde transvenous obliteration (BRTO) is widely used to treat isolated gastric varices (IGVs) in Japan. However, BRTO is difficult to perform for IGVs with many small collateral veins, and no secondary treatment has been established. We herein report a rare case of IGVs refractory to BRTO successfully treated by shunt-occluded endoscopic injection sclerotherapy (SO-EIS), which is a combination therapy of major shunt occlusion by a balloon catheter and endoscopic injection sclerotherapy. Since SO-EIS can be performed regardless of the IGVs' anatomical configuration, it may be a promising alternative treatment for IGVs refractory to BRTO.

Keywords: balloon-occluded retrograde transvenous obliteration (BRTO); isolated gastric varices; shunt-occluded endoscopic injection sclerotherapy (SO-EIS).

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(a) Esophagogastroduodenoscopy (EGD) showed that the isolated gastric varices (IGVs) were white, large, and located in the cardia and fundus. (b, c) Dynamic computed tomography (CT) also showed that IGVs were in the cardia and fundus, suggesting that the left renal vein was the efferent vein.
Figure 2.
Figure 2.
The portal phase of superior mesenteric angiography showed that portal flow was hepatopetal, and the IGVs were not visualized (a). CT of splenic arterial portography showed that the efferent veins were the pericardiacophrenic vein (red arrow) (b), inferior phrenic vein (red triangle), para-esophageal vein (blue arrow) (c), and left renal vein (yellow arrow), which was the main drainage route afferent vein (d). CT also showed that the short gastric vein (green arrow) was the afferent vein (e).
Figure 3.
Figure 3.
Balloon-occluded retrograde transvenous varicerography (BRTV) showed that the IGVs were not opacified because the inferior phrenic veins (red arrow) worked as collateral veins. (a) Frontal view, (b) lateral view.
Figure 4.
Figure 4.
We punctured the right internal jugular vein and introduced an 8-Fr balloon catheter with a 20-mm diameter. We advanced it to the left renal vein and occluded the end of the efferent vein (a). We then tried to cannulate the inferior phrenic vein from the inferior vena cava (IVC). We injected contrast medium via the balloon catheter and performed CT to determine where the end of the inferior phrenic vein was located (b, c). Although we used various types of catheter, such as Cobra, Multipurpose, and Michaelson types, we were unable to cannulate due to indentation.
Figure 5.
Figure 5.
Shunt-occluded endoscopic injection sclerotherapy (SO-EIS) procedure. (a, b) First puncture. (c, d) Second puncture. (e) Just after the treatment.
Figure 6.
Figure 6.
One week after shunt-occluded endoscopic injection sclerotherapy (SO-EIS), esophagogastroduodenoscopy (EGD) and enhanced computed tomography (CT) showed complete thrombosis of the isolated gastric varices (IGVs) and afferent vein (a-c). Three months after SO-EIS, EGD showed that the IGVs had shrunk (d).

References

    1. Watanabe K, Kimura K, Matsutani S, Ohto M, Okuda K. Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and/or gastric varices using portal vein catheterization. Gastroenterology 95: 434-440, 1988. - PubMed
    1. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology (Baltimore, Md) 16: 1343-1349, 1992. - PubMed
    1. Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 362: 823-832, 2010. - PubMed
    1. Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 11: 51-58, 1996. - PubMed
    1. Akahoshi T, Hashizume M, Tomikawa M, et al. . Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. J Gastroenterol Hepatol 23: 1702-1709, 2008. - PubMed

MeSH terms